Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLIC

Sponsor
Institut Pasteur (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04836208
Collaborator
Institut Pasteur de Madagascar (Other), Centre hospitalier de référence du District de Moramanga (Other)
600
1
24
25

Study Details

Study Description

Brief Summary

Enterobacteriaceae, more specifically Escherichia coli and Klebsiella pneumoniae, are the bacteria most often responsible for neonatal infections in low-income countries. Infections caused by multidrug-resistant Enterobacteriaceae: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), are more often associated with an unfavorable outcome of the infection.

Enterobacteriaceae colonize the digestive tract which is the first step in developing a potential infection. Very few studies have been carried out at the community level. Colonization of the mother with ESBL-E is generally considered to be a major route of acquisition. The carrying of ESBL-E by other family members and other potential sources of transmission (food, objects and surfaces in contact with the newborn) have never been documented.

In addition, with a view to offering an intervention adapted to the local context, the local cultural determinants which govern the interactions of the newborn with his environment are important to understand.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a single-center prospective cohort of all members living in the same household in which a newborn baby has just been born.

    The study consists to:
    • recruit a cohort of all members of 60 households in which a newborn has just been born

    • carry out semi-structured interviews and direct participant observation.

    This study is divided in two parts :
    • the epidemiological part : the documentation of colonization by E-ESBL by sampling the stools of the newborn, of all members of the household, and sampling of food given to the child, from surfaces in contact with it.

    • the anthropological part : Semi-structured interviews with key people in the structuring of the social and family environment of the newborn and participant direct observation of households.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    600 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Neonatal Acquisition of ESBL-PE in a Low-income Country
    Actual Study Start Date :
    Apr 30, 2021
    Anticipated Primary Completion Date :
    May 1, 2023
    Anticipated Study Completion Date :
    May 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Number of acquisition events and the number of non-acquisition of E-ESBL in newborns for the epidemiological part [2 years]

      Identification of bacterial strains from stool and sequencing of EBSL-E strains

    2. Number of semi-structured interviews completed for the anthropological part [2 years]

      1 or 4 hours semi-structured interviews of participants at home done by investigators

    3. Number of participant direct observation completed for the anthropological part [2 years]

      observations of the participants at home done by investigators (2 to 4 hours in 3 to 4 sessions over 28 days)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. For the epidemiological study :

    All members of 60 households in which a newborn baby has just been born

    Inclusion criteria for the mother at the time of childbirth, pregnant woman :

    _ having a monofetal pregnancy

    • residing regularly in the study area OR planning to reside in the study area during the study period;

    • having been informed of the research and collection of biological samples on herself and her newborn;

    • having given its agreement to carry out the research and the associated collection of biological samples, and;

    • having signed the informed consent (or its witness if applicable).

    Inclusion criteria for the live newborn at the time of childbirth, new born :
    • living after childbirth;

    • whose parents or legal representatives present:

    • reside regularly in the study area or plan to reside in the study area during the study period;

    • were informed of the research and the associated collection of biological samples on their newborn;

    • have given their agreement to carry out the research and the associated collection of biological samples,

    Inclusion criteria for the household member, resident:
    • from the same household as the mother-child (ren) couple included

    • Residing at least 4 nights per week in this home

    • Having given its agreement to carry out the research and the associated collection of biological samples,

    • and having signed the consent of the study (or its witness, or its legal representative if applicable)

    1. for the anthropological study with interviews : 16 homes will be selected from among the 60 homes included: 8 homes in which the child has not acquired an ESBL-E during the entire follow-up and 8 homes in which the child has acquired an ESBL-E at least once during its follow-up. Among these households, interviews will be carried out with: 16 mothers or first responsible for the child in the absence of the mother 4 people with a mothering role on the child (grandmother, aunts ...) 4 minors in the families to observe 4 fathers or father figures in families to observe
    Also, interviews will be done with:

    Health actors: medical (1 midwife and 1 neighborhood doctor) and traditional (1 matron and 1 traditional practitioner from the neighborhood), 1 community health worker 1 neighborhood chief

    Inclusion criteria for semi-structured interviews :
    • people responding to the structuring functions of the child's social and family environment

    • Having given its agreement to carry out the research,

    • and having signed the consent of the study (or its witness, or its legal representative if applicable)

    For health workers and district managers, inclusion criteria for semi-structured interviews :

    • people responding to the targeted functions

    • working in the district of homes included

    • Having given its agreement to carry out the research,

    • and having signed the consent of the study (or its witness, or its legal representative if applicable)

    1. For the anthropological study with observations 4 households in total among the 16 initially selected for the interviews: 2 households in which the child did not acquire ESBL-E during all the follow-up and 2 households in which the child acquired at least once an BLSE-E during his follow-up Inclusion criteria for participating direct observations
    • Residents of the same household as the mother-child (ren) couple included

    • having agreed to participate in the study

    • Having given its agreement to carry out the research,

    • and having signed the consent of the study (or its witness, or its legal representative if applicable)

    Exclusion Criteria:
    1. For the epidemiological part:
    • Pregnant woman: non-monofetal pregnancy

    • Newborn: died during childbirth

    • Household resident: None

    1. and 3) For the anthropological part: • Semi-structured interview:
    For household members:
    • not responding to the structural family and social functions of the child's environment For health workers and district managers

    • people not meeting the targeted functions

    • not practicing in the district of homes included

    • Participant direct observation:

    • Not living in the same household as the mother-child couple included

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Institut Pasteur de Madagascar Antananarivo Madagascar

    Sponsors and Collaborators

    • Institut Pasteur
    • Institut Pasteur de Madagascar
    • Centre hospitalier de référence du District de Moramanga

    Investigators

    • Study Director: Bich-Tram Huynh, Institut Pasteur

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Institut Pasteur
    ClinicalTrials.gov Identifier:
    NCT04836208
    Other Study ID Numbers:
    • 2020-059
    First Posted:
    Apr 8, 2021
    Last Update Posted:
    Aug 31, 2021
    Last Verified:
    Aug 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Institut Pasteur
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 31, 2021